61 related articles for article (PubMed ID: 713173)
21. [Cataract during intermittent hemodialysis. The influence of hypocalcemia on the development of opacities (author's transl)].
Koch HR; Siedek M; Weikenmeier P; Metzler U
Klin Monbl Augenheilkd; 1976 Mar; 168(3):346-53. PubMed ID: 966565
[TBL] [Abstract][Full Text] [Related]
22. Treatment of osteoporosis of ageing with 1alpha-hydroxycholecalciferol.
Lund B; Hjorth L; Kjaer I; Reimann I; Friis T; Andersen RB; Sorensen OH
Lancet; 1975 Dec; 2(7946):1168-71. PubMed ID: 53656
[TBL] [Abstract][Full Text] [Related]
23. [Effect of 1 alpha-hydroxycholecalciferol on hypocalcemia and renal function of chronic renal failure (author's transl)].
Takeda K; Kusano E; Asano Y; Hosoda S
Nihon Jinzo Gakkai Shi; 1981 Jan; 23(1):13-25. PubMed ID: 7289202
[No Abstract] [Full Text] [Related]
24. Clinical effects of 25-hydroxycholecalciferol in patients with chronic renal failure.
Matsushita Y; Hasegawa K; Otomo S; Morii H; Okamoto T
J Nutr Sci Vitaminol (Tokyo); 1977; 23(3):257-61. PubMed ID: 915557
[No Abstract] [Full Text] [Related]
25. Curative effects of 1alpha-hydroxycholecalciferol on calcium metabolism and bone disease in patients with chronic renal failure.
Hirooka M; Wako H; Kaneko C; Ishikawa M; Sasaki S
J Nutr Sci Vitaminol (Tokyo); 1975; 21(4):277-85. PubMed ID: 1214180
[TBL] [Abstract][Full Text] [Related]
26. [The effect of 1a-OH-D3 on rheumatoid arthritis--results from over one year's study].
Miyamoto S; Inoue T; Kushida K; Denda M; Mizoguchi M; Suzuki M; Yamashita G
Ryumachi; 1985 Sep; 25(4):253-7. PubMed ID: 4081904
[No Abstract] [Full Text] [Related]
27. [25 OH CC (25-hydroxycholecalciferol in spasmophilia) (author's transl)].
Klotz HP; Merceron RE; Konopka P; Roger-Aussenard C
Ann Endocrinol (Paris); 1979; 40(4):443-4. PubMed ID: 518027
[TBL] [Abstract][Full Text] [Related]
28. [Effects of long-term 1alpha-(OH) D3 therapy on the hyperparathyroidism of children on maintenance hemodialysis (proceedings) (author's transl)].
Balsan S; Lévy D; Guéris J; Garabédian M; Broyer M
Ann Endocrinol (Paris); 1978; 39(3):221-2. PubMed ID: 718122
[No Abstract] [Full Text] [Related]
29. [Long-tern effect of hemodialysis without heparin on abnormal lipid metabolism in patients on regular dialysis treatment (author's transl)].
Matsui N; Shinoda T; Akiba T; Yoshiyama N; Nakagawa S; Takeuchi J; Teraoka J
Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1225-32. PubMed ID: 7328898
[No Abstract] [Full Text] [Related]
30. 1-Alpha-hydroxycholecalciferol in the treatment of hypocalcaemic psychosis.
Gertner JM; Hodsman AB; Neuberger JN
Clin Endocrinol (Oxf); 1976 Sep; 5(5):539-43. PubMed ID: 186220
[TBL] [Abstract][Full Text] [Related]
31. [Studies on bone disease and serum A1-P isozymes of patient on long term regular hemodialisis (author's transl)].
Maruyama Y; Suemori R; Aoyama H; Hijioka T; Shiomi T; Ijuin M; Motomiya Y; Hiramatsu T; Okajima E; Komada S; Kondo TU
Nihon Jinzo Gakkai Shi; 1982 Jan; 24(1):63-70. PubMed ID: 7098136
[No Abstract] [Full Text] [Related]
32. Treatment of the rickets of cystinosis with 1-alpha-hydroxycholecalciferol.
Gertner JM; Brenton DP; Dent CE; Domenech M
Calcif Tissue Res; 1977 May; 22 Suppl():63-7. PubMed ID: 912591
[No Abstract] [Full Text] [Related]
33. [Biological activity of 1alpha-hydroxycholecalciferol (II). Effect on the metabolism of calcium and phosphorus in rats (author's transl)].
Kawashima H; Hoshina K; Okamiya Y; Makita T; Hashimoto Y; Noguchi T; Orimo H
Nihon Yakurigaku Zasshi; 1978 Apr; 74(3):361-82. PubMed ID: 669482
[TBL] [Abstract][Full Text] [Related]
34. [Hydroxylated vitamin D metabolites, therapeutical uses of 1-alpha-hydroxycholecalciferol (author's transl)].
Vokrouhlická O; Horn V; Stĕpán J; Justová V; Erben J; Lachmanová J; Pacovský V
Cas Lek Cesk; 1979 Nov; 118(46):1424-8. PubMed ID: 535019
[No Abstract] [Full Text] [Related]
35. [Primary hypoparathyroidism with epilepsia in adult. Effects of 25 OH-cholecalciferol (author's transl)].
Codaccioni JL; Palayodan A; Saier J; Gastaut H
Ann Endocrinol (Paris); 1974; 35(5):591-2. PubMed ID: 4463808
[No Abstract] [Full Text] [Related]
36. Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium.
Sørensen OH; Lund B; Saltin B; Lund B; Andersen RB; Hjorth L; Melsen F; Mosekilde L
Clin Sci (Lond); 1979 Feb; 56(2):157-61. PubMed ID: 477197
[TBL] [Abstract][Full Text] [Related]
37. The use of 1alpha-hydroxyvitamin D3 in the management of patients undergoing parathyroidectomy.
Parsons V; Jones R; Weston M; Lucas P; Snowden S; Keenan J; Packham D
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():223s-224s. PubMed ID: 606420
[No Abstract] [Full Text] [Related]
38. Observations on calcium metabolism in the nephrotic syndrome.
Jones JH; Peters DK; Morgan DB; Coles GA; Mallick NP
Q J Med; 1967 Jul; 36(143):301-20. PubMed ID: 6049764
[No Abstract] [Full Text] [Related]
39. The treatment of hypoparathyroidism with 1alpha-hydroxycholecalciferol.
Brenton DP; Dent CE; Gertner JM
Calcif Tissue Res; 1977 May; 22 Suppl():545-52. PubMed ID: 912584
[No Abstract] [Full Text] [Related]
40. 1alpha-hydroxyvitamin D in neonatal hypocalcaemia.
Doxiadis SA; Lapatsanis PD
Lancet; 1977 Feb; 1(8008):426. PubMed ID: 65537
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
